North Capital, Inc. Merck & Co., Inc. Transaction History
North Capital, Inc.
- $106 Billion
- Q1 2025
A detailed history of North Capital, Inc. transactions in Merck & Co., Inc. stock. As of the latest transaction made, North Capital, Inc. holds 3,108 shares of MRK stock, worth $263,278. This represents 0.26% of its overall portfolio holdings.
Number of Shares
3,108Holding current value
$263,278% of portfolio
0.26%Shares
1 transactions
Others Institutions Holding MRK
# of Institutions
3,920Shares Held
1.85BCall Options Held
16MPut Options Held
15M-
Vanguard Group Inc Valley Forge, PA251MShares$21.3 Billion0.45% of portfolio
-
Black Rock Inc. New York, NY207MShares$17.6 Billion0.59% of portfolio
-
State Street Corp Boston, MA121MShares$10.2 Billion0.49% of portfolio
-
Geode Capital Management, LLC Boston, MA61.2MShares$5.18 Billion0.48% of portfolio
-
Morgan Stanley New York, NY44.2MShares$3.74 Billion0.32% of portfolio
About Merck & Co., Inc.
- Ticker MRK
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 2,533,280,000
- Market Cap $215B
- Description
- Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...